ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

0Y71 Malin Corporation Plc

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type Share ISIN Share Description
Malin Corporation Plc LSE:0Y71 London Ordinary Share IE00BVGC3741 MALIN CORPORATION ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Offices-holdng Companies,nec 0 12.9M - N/A 0

Malin Corporation PLC Board Update (5389Y)

09/05/2019 11:44am

UK Regulatory


Malin (LSE:0Y71)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Malin Charts.

TIDM0Y71

RNS Number : 5389Y

Malin Corporation PLC

09 May 2019

Board Malin Corporation plc

("Malin" or "the Company")

Board Update

Dublin-Ireland, 9 May 2019: Malin Corporation plc (Euronext Growth Dublin:MLC), a company investing in highly innovative life sciences companies, announced a board update at its Annual General Meeting held in Dublin today.

In October 2018, Mr. Ian Curley, Chairman of Malin moved into an Executive Chairman role on an interim basis, in order to support the executive management team. Mr. Curley will resume the role as Non-Executive Chairman. As the business progresses towards the previously communicated important milestones and value inflection points, the Company will seek to appoint a new Non-Executive Chairman with healthcare industry experience to further progress the business and Mr. Curley will transition off the board.

A summary of the voting results of the Annual General Meeting of the Company will be available later today on the Company's website www.malinplc.com.

ENDS

For further information, please contact:

Malin

Jessica Bergin, Director of Investor Relations & External Reporting

Tel: +353 (0)1 901 5700

investorrelations@malinplc.com

Davy Corporate Finance (Euronext Growth Adviser)

Brian Garrahy / Daragh O'Reilly

Tel: +353 1 679 6363

Consilium Strategic Communications

Mary-Jane Elliott / Jessica Hodgson

Tel: +44 (0)20 3709 5700

malin@consilium-comms.com

Powerscourt (Irish media enquiries)

Jack Hickey

Tel: +353 83 448 8339

malin@powerscourt-group.com

About Malin Corporation plc

Malin (Euronext Growth Dublin:MLC) is a company investing in and supporting highly innovative life sciences companies developing exceptional science and technology to deliver transformative outcomes for patients and create significant value for shareholders. Its purpose is to create shareholder value through the application of long-term capital and strategic support to its investee companies to enable them to reach their value potential. Malin is headquartered and domiciled in Ireland and listed on the Euronext Growth Dublin. For more information visit www.malinplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

BOADMGGKGLGGLZM

(END) Dow Jones Newswires

May 09, 2019 06:44 ET (10:44 GMT)

1 Year Malin Chart

1 Year Malin Chart

1 Month Malin Chart

1 Month Malin Chart

Your Recent History

Delayed Upgrade Clock